Results 41 to 50 of about 37,190 (230)
Health Care Science, EarlyView.This study validates a novel Breast Modular Resection (BMR) teaching model for breast‐conserving surgery under regional anesthesia. The BMR approach significantly improves surgical proficiency, reduces re‐excision rates and pain, and facilitates safe day‐case discharge with superior cosmetic outcomes. ABSTRACT Background Breast‐conserving surgery (BCS)
Ru Yao +7 more
wiley +1 more source
De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer
International Journal of Cancer, EarlyView.ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley +1 more source
BMJ Open, 2023 Objective To compare the long-term psychosocial consequences of mammography screening among women with breast cancer, normal results and false-positive results.Design A matched cohort study with follow-up of 12–14 years.Setting Denmark from 2004 to 2019 ...
Volkert Siersma +2 more
doaj +1 more source
International Journal of Cancer, EarlyView.ABSTRACT There is no study from Germany on the association between stage of lung cancer (LC) and patient characteristics. We aimed to compare advanced versus non‐advanced LC cases regarding indicators of healthcare utilization. Using claims data covering 20% of the German population, we included LC patients diagnosed between 2013 and 2019.
Josephine Küsel‐Kanbach +2 more
wiley +1 more source
Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis
BMC Medical Imaging, 2021 Background Breast cancer is the most common cancer diagnosed in women. Screening mammography is the only imaging screening study for breast cancer with a proven. mortality benefit.
Segni Kejela
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundBRCA1/2 mutation carriers are suggested with regular breast cancer surveillance screening strategies using mammography with supplementary MRI as an adjunct tool in Western countries.
Jiaxin Li +12 more
doaj +1 more source
International Journal of Cancer, EarlyView.ABSTRACT Breast cancer progression varies across molecular subtypes, influencing detection rates and prognosis. Differences in the proportion of interval cancers (PIC)—cancers detected symptomatically between scheduled screening rounds—have been observed across subtypes, likely reflecting heterogeneity in tumour growth dynamics. We applied a continuous‐
Letizia Orsini +3 more
wiley +1 more source
Screening Mammography Guidelines [PDF]
Radiology, 2015 I thank Dr Meyer for his kind remarks. One would think that time would resolve most scientific controversies, even those that have endured for decades. However, no amount of historic retrospection will probably fully answer the questions raised by screening mammography.
openaire +2 more sources
iMeta, EarlyView.The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Journal of Magnetic Resonance Imaging, EarlyView.ABSTRACT Background MR cytometry imaging is developed to characterize in vivo microstructures. Its clinical value in predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer remains unknown. Purpose To implement MR cytometry to predict pCR for breast cancer and compare the performance of different ...
Jie Ding +10 more
wiley +1 more source